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Abstract: Lichens are recently receiving great attention because they have potential anticancer activity. Therefore, in this study, genotoxic
and antigrowth properties of lichen species Usnea filipendula Stirt. were tested against human breast cancer cell lines (MCF-7 and MDAMB-231). Antigrowth effect was assayed by the MTT and ATP viability assays. Cell death modes (apoptosis/necrosis) were evaluated
morphologically (fluorescence staining) and biochemically (caspase-cleaved cytokeratin 18, caspase-3 activity, and poly-(ADP-ribose)
polymerase (PARP) cleavage). Genotoxic activity of U. filipendula was determined by using micronucleus, chromosomal aberration,
and comet assays in human lymphocyte culture. U. filipendula inhibited growth in a dose-dependent manner and induced apoptosis by
cleavage of PARP and induction of active caspase-3. It also showed genotoxic activity in doses (125 and 250 µg/mL) higher than that
required for apoptosis. These results suggest that U. filipendula may induce apoptotic cell death at lower doses, while it may be genotoxic
at higher doses.
Key words: Usnea filipendula, breast cancer, cell death, apoptosis, DNA damage

1. Introduction
Natural products play an important role in cancer therapy
with substantial numbers of anticancer agents used in the
clinic being either natural or derived from natural products
from various sources (Mann, 2002). Recently, extracted
lichen and lichen compounds as alternative materials of
natural therapeutic products have attracted considerable
attention from scientists. Lichens are complex organisms
living in a symbiotic relationship with fungi and algae (and/
or Cyanobacteria) (Müller, 2001). These associations give rise
to a great number of secondary metabolites, the majority of
which are unique to these organisms. Lichen substances have
several possible biological activities: antibiotic, antiviral,
antitumor, antimutagenic, antioxidant, antiinflammatory,
antiproliferative, and cytotoxic (Müller, 2001; Oksanen,
2006; Molnar and Farkas, 2010; Mitrović et al., 2011).
Usnea filipendula belongs to the family Parmeliaceae and
contains salazinic and usnic acid (Purvis et al., 1994; Brodo
et al., 2001). Usnic acid, one of the most studied lichen
compounds, was found to be effective against different
types of cancer cell lines (Bačkorová et al., 2011). Salazinic
acid, which is a major metabolite in P. sulcata, was found
to possess high cytotoxic activity in human melanoma and
* Correspondence: seyhana@uludag.edu.tr

940

colon cancer cell lines (Manojlović et al., 2012). In a recent
study, methanol extracts of Usnea articulata and Usnea
filipendula were reported to have strong antioxidative and
antigenotoxic effects (Ceker at al., 2013). Anticancer activity
of Hypogymnia physodes and Parmelia sulcata against breast
cancer cell lines and genotoxic effect on human lymphocytes
were previously investigated by our research group (Ari et
al., 2014b, 2014c).
We think that further work needs to be done on the
cytotoxic and genotoxic effects of lichens. Thus, in the
present study, cytotoxic and genotoxic activities of the
methanol extract of U. filipendula (UFE) were investigated
in breast cancer cell lines and human lymphocytes,
respectively.
2. Materials and methods
2.1. Lichen samples
U. filipendula was collected from the trunks of Quercus
sp. (Mount Uludağ, Bursa, Turkey) in May 2010 and
identified with the aid of flora books (Purvis et al., 1994;
Wirth, 1995). A voucher specimen has been deposited
in the Herbarium of Uludağ University (BULU), Bursa,
Turkey.
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2.2. Extraction
An air-dried lichen sample was carefully cleansed of
extraneous materials and ground into powder; 15 g of the
ground material was extracted consecutively by adding 150
mL of solvent methanol (Merck) and water to a Soxhlet
extractor for 24 h. The crude extracts were concentrated
using a rotary evaporator at 40 °C; thereafter, the residues
were lyophilized and stored at –20 °C until used in the
tests.
2.3. Determination of cytotoxicity
2.3.1. Cell culture and chemicals
Breast cancer cell lines (MCF-7 and MDA-MB-231) were
cultured in RPMI 1640 supplemented with penicillin G
(100 U/mL), streptomycin (100 µg/mL), L-glutamine, and
5% fetal calf serum (Invitrogen, Paisley, UK) at 37 °C in
a humidified atmosphere containing 5% CO2. Lyophilized
U. filipendula was dissolved in DMSO at a concentration
of 0.05 g/0.5 mL, while the final concentrations were
prepared in culture medium.
2.3.2. The MTT viability assay
MCF-7 or MDA-MB-231 cells were seeded in 200 µL of
culture medium in triplicate at a density of 5 × 103 cells per
well of a 96-well plate. Cells were incubated either alone
(for control including 0.1% DMSO) or in the presence of
UFE (1.56 to 100 µg/mL) for 72 h. Each experiment was
conducted twice in triplicate. A 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazoliumbromide (MTT) viability
assay was performed as previously described (Ulukaya et
al., 2008). MTT was first prepared as a stock solution of 5
mg/mL in phosphate buffer (PBS, pH 7.2) and was filtered.
At the end of the treatment period (72 h), 20 μL of MTT
solution (5 mg/mL PBS, pH 7.2) was added to each well.
After incubation for 4 h at 37 °C, 100 μL of solubilizing
buffer (10% sodium dodecyl sulfate dissolved in 0.01 N
HCl) was added to each well. After overnight incubation,
the absorbance (Abs) was read by an ELISA plate reader
(FLASH Scan S12, Analytik Jena, Germany) at 570 nm
to determine cell viability. Viability of treated cells was
calculated in reference to the untreated control cells by
using the following formula:
Cell viability (%) = [100 × (Sample Abs)/(Control
Abs)].
2.3.3. The ATP viability assay
The seeding of cells and treatment conditions as well as the
calculation of viability were similar to those of the MTT
assay (see above). The ATP assay uses the highly sensitive
reaction to determine the level of cellular ATP as a surrogate
marker for the number of viable (ATP-producing) cells
(Andreotti et al., 1995). ATP content was determined
according to the manufacturer’s recommendations (ATP
Bioluminescence Assay, Sigma, St. Louis, MO, USA).
Briefly, following the treatment, ATP was extracted from

the cells, and then luciferin-luciferase solution was added.
Luminescence was determined in a luminometer (BioTek, USA).
2.4. Determination of apoptosis
2.4.1. Caspase-cleaved cytokeratin 18 (M30) detection
Apoptosis was assayed by measuring the level of caspasecleaved keratin 18 (ccK18, M30) by a commercially
available immunoassay kit (M30-Apoptosense ELISA
kit, Peviva AB, Sweden) according to the manufacturer’s
instructions. This kit measures the levels of the CK18Asp396 neo-epitope (M30), which is a well-known marker
of apoptosis. Cells (1 × 104 per well of a 96-well plate) were
seeded in 200 µL of culture medium in triplicate. MCF-7 or
MDA-MB-231 cells were treated for 72 h with 100 µg/mL
of UFE. Paclitaxel (3.12 µM) was used as a positive control
for apoptosis as this agent is considered an appropriate
apoptosis inducer (Park et al., 2004). At the end of the
treatment period, the cells were lysed with 10% NP-40 for
10 min on a shaker. The contents of identical wells were
pooled and centrifuged at 2000 rpm for 10 s to remove the
debris. All samples were placed into wells coated with a
mouse monoclonal antibody as a catcher. After washing,
a horseradish peroxidase conjugated antibody (M30) was
used for detection. The absorbance was determined with
an ELISA reader at 450 nm (FLASH Scan S12, Eisfeld,
Germany).
2.4.2. Fluorescence imaging for apoptosis
The seeding and treatment conditions as well as the
detection of apoptosis were based on both the nuclear
morphology of cells and their membrane integrity
using a fluorescent microscope (Cevatemre et al., 2013).
Therefore, the nuclear and membrane morphology of
living (not fixed) cells was examined after staining them
with fluorescent dyes, Hoechst 33342, calcein-AM,
and propidium iodide (PI) (Cell Viability Imaging kit,
Roche, Mannheim, Germany). Cells were analyzed with a
fluorescent microscope at the end of the incubation.
2.4.3. Measurement of active caspase-3 and cleaved
PARP levels
MCF-7 and MDA-MB-231 cells (1 × 106) were seeded in
25-cm2 flasks and treated with 100 µg/mL of UFE for 72 h
in order to detect active caspase-3 and cleaved poly(ADPribose) polymerase (PARP), which are the markers for
apoptosis. After treatment, cells were washed in ice-cold
PBS, and lysed in lysis buffer (Cell Signaling, MA, USA)
containing protease inhibitors (Sigma, St. Louis, MO,
USA) and 1 mM of phenylmethylsulfonyl fluoride (PMSF).
Cells were extracted at 4 °C for 5 min, and centrifuged at
4 °C for 10 min at 14,000 × g. The level of cleaved PARP
was estimated using the PARP Cleavage [214/215] human
ELISA kit (Invitrogen, UK) and active caspase-3 level was
determined with the Caspase-3 (Active) human ELISA
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kit (Invitrogen, UK) according to the protocols described
in the manufacturer’s instructions. For determination of
active caspase-3, 100 µL of cell lysates was incubated in the
microplate wells provided in the kit at room temperature
for 2 h. The samples were aspirated and washed 4 times
with washing buffer and incubated with 100 µL of
detection antibody (anti-active caspase-3) for 1 h at room
temperature. After removal of the antibody solution, the
wells were washed again and incubated with 100 µL of
HRP anti-rabbit antibody for 30 min at room temperature.
After the aspiration of the anti-rabbit antibody, a blue color
was developed by adding 100 µL of stabilized chromogen
solution for 20 min at room temperature. The reaction was
stopped after the addition of 100 µL of stopping solution.
For determination of cleaved PARP levels, 50 µL from each
lysate was incubated with anti-cleaved PARP (detection
antibody) for 3 h. After washing, each sample in a well was
incubated with a secondary antibody, IgG-HRP solution,
for 30 min. Stabilized chromogen was added to each
well for another 30 min followed by addition of stopping
solution. The absorbance of each well was read at 450 nm
using a microplate reader.
The level of cleaved PARP was also determined by
using Western blotting. MCF-7 cells were seeded in 75-cm2
flasks and treated when the cells reached 70% confluence
with 100 µg/mL of UFE for 72 h. Western blotting was
performed using rabbit anti-PARP monoclonal antibody
(1:1000 dilution; Cell Signaling, MA, USA) and rabbit
anti-β-actin monoclonal antibody (1:1000 dilution; Cell
Signaling, MA, USA). Bound antibodies were visualized
on a Fusion FX-7 imaging device (Vilber Lourmat, Torcy,
France).
2.5. Genotoxicity assays
Genotoxicity assays were performed as described in our
previous study (Ari et al., 2014b). UFE was dissolved
in 50% DMSO. A preliminary study was conducted to
determine UFE doses (50, 100, 125, 250, 400, 500, and
750 µg/mL). The cells were then treated separately with
a mutagenic agent, DMSO, as solvent control and diluted
sterile UFE (125, 250, and 500 µg/mL) for 24 h prior to
harvest. Metaphases were obtained by adding colcemid
(0.2 µg/mL final concentration, Sigma) 2 h prior to
harvest. For the micronucleus (MN) assay, cytochalasin
B (6 µg/mL) was added at 44 h to block the cytokinesis
process, and lymphocyte cultures were harvested after
72 h (Fenech, 2000). Chromosomes were prepared using
standard procedures (Benn and Perle, 1992). Staining of
the micronuclei was performed by immersing the airdried slides in a 2% Giemsa solution.
2.5.1. Microscopic evaluation
The analysis of chromosomal aberrations (CAs) was
performed in 50 metaphases for each culture. Total CA
results were evaluated for both cases in which gaps and
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pulverisations were included and excluded. The CAs were
classified according to the Environmental Health Criteria
51 for Short-term Tests for Mutagenic and Carcinogenic
Chemicals (IPCS, 1985).
For the determination of MN, 2000 binucleated cells
for each experimental point were examined following
the scoring criteria adopted by the Human Micronucleus
Project (Bonassi et al., 2001). We evaluated the binucleated
micronucleated lymphocytes frequency as the number of
binucleated lymphocytes containing 1 or more MN per
1000 binucleated cells.
2.5.2. Mitotic index (MI) and nuclear division index
(NDI)
The MI was calculated from the number of metaphases
in 2000 cells analyzed per culture for each dose group
and donor in the CA assay. In the micronuclei assay, 500
lymphocytes were scored to evaluate the percentage of
binucleated cells, and the NDI was calculated according to
the following formula:
NDI= [MONO + 2BN + 3TRI + 4TETRA]/500,
where MONO, BN, TRI, and TETRA were mononuclear,
binucleated, trinucleated, and tetranucleated lymphocytes,
respectively.
2.5.3. Comet assay
The alkaline version of the comet assay was used (Singh
et al., 1988) with some modifications. Venous blood
samples from healthy donors (0.5 mL) were mixed with
5 mL of RPMI 1640 medium supplemented with 20%
fetal calf serum, 1% penicillin/streptomycin (100 U/mL),
and 2.5% phytohemagglutinin. The lymphocyte culture
was incubated for 72 h at 37 °C. UFE (125, 250, and 500
µg/mL) and ethyl methanesulfonate (EMS, 1250 µg/mL,
as positive control) were added 24 h prior to the end of
incubation. The cells were lysed and electrophoresis was
performed at 25 V for 30 min. The slides stained with
ethidium bromide were visualized under a microscope
with a fluorescence attachment. The images were analyzed
by using specialized software for comet analysis (Kameram
21, Argenit, İstanbul, Turkey). Comet square, comet
length, comet density, tail length, tail DNA percentage,
tail moment length, olive moment length, head DNA%,
genetic damage index (GDI), and percentage of damaged
cell parameters were evaluated for each cell.
GDI was calculated according to the following formula
used by the comet analysis program (Singh et al., 1988),
GDI = (1 × ΣType1) + (2 × ΣType2) + (3 × ΣType3)
+ (4 × ΣType4)/(ΣType0 + ΣType1 + ΣType2 + ΣType3 +
ΣType4)
(ΣType 0: Total of undamaged cells; ΣType 1: Total of
very low damaged cells; ΣType 2: Total of low damaged
cells; ΣType 3: Total of high damaged cells; ΣType 4: Total
of very high damaged cells).
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3. Results and discussion
3.1. Cytotoxic activities of UFE by the MTT and ATP
assays
The antigrowth (cytotoxic) effect of UFE (1.56–100 µg/
mL) was investigated on MCF-7 and MDA-MB-231
human breast cancer cell lines by the MTT (Figure 1A)
and ATP assays (Figure 1B) for 72 h. It was found that
UFE exhibited the antigrowth effect in a dose-dependent
manner (P < 0.05). According to the dose response curves,
UFE had a stronger growth-inhibitory effect on MCF7 cells than on MDA-MB-231 cells. IC50 values (50%
inhibitory concentration) of UFE were calculated on the
basis of ATP assay results. UFE clearly resulted in cytotoxic
activity on MDA-MB-231 cells (44.7 µg/mL), but it was
more cytotoxic to MCF-7 cells (23.0 µg/mL).
In our previous study, we investigated the
antiproliferative/apoptotic effects of methanol extracts of
U. filipendula and P. sulcata on human lung cancer (A549,
PC3), liver cancer (Hep3B), and rat glioma (C6) cells.
We found that the lichen species induced apoptosis-like
cell death by causing DNA damage to cancer cells (Ari
et al., 2014a). The antigrowth effects of UFE may arise
from its secondary metabolites. U. filipendula contains
salazinic and usnic acids (Purvis et al., 1994; Brodo et al.,
2001). Salazinic acid was found to possess high cytotoxic
activity in human melanoma and colon cancer cell lines
(Manojlović et al., 2012) and usnic acid had a potent
cytotoxic effect through apoptosis in A549 lung cancer
cells (Singh et al., 2013).
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Figure 2. M30 (U/L) levels 72 h after treatment with Usnea
filipendula extract (UFE) in MCF-7 and MDA-MB-231 breast
cancer cells. Paclitaxel was used as positive control for M30
increase (apoptosis). * Denotes significant change from control
(P < 0.05).
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3.2. Apoptosis-inducing effect of UFE on MCF-7 and
MDA-MB-231 breast cancer cells
The apoptosis inducing effects of UFE was investigated by
M30 assay. Figure 2 shows that M30 levels (a marker of
apoptosis) were not changed in MDA-MB-231 cells after
72 h of treatment with different concentrations (12.5–100
µg/mL) of UFE. In contrast, M30 levels were significantly
increased in MCF-7 cells with 50 and 100 µg/mL UFE
treatment (P < 0.05), suggesting an apoptosis-inducing
effect of UFE in MCF-7 cells (Figure 2).
There are several studies reporting that lichen or
lichen compounds resulted in apoptosis in different types
of cancer cell lines (Mitrović et al., 2011; Russo et al.,
2012; Singh et al., 2013). In our study, M30 levels were
significantly increased in MCF-7 cells after the treatment

M30 Level (U/L)

2.6. Statistical analyses
All statistical analyses were performed using SPSS 20.0
for Windows. The significance was calculated using oneway analysis of variance and Tukey’s honest significant
difference tests with 95% confidence intervals. A value of P
< 0.05 was considered statistically significant. Results were
expressed as mean ± SD.
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Figure 1. Assessment of viability of MCF-7 and MDA-MB-231 cell lines after 72 h of treatment with varying
doses of Usnea filipendula extract (UFE) *Denotes significant differences in comparison with control (P < 0.05).
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with UFE. However, MDA-MB-231 cells did not exhibit
any increase in M30 levels, implying that the mode of cell
death may be different from apoptosis or other reasons
regarding the genomic status of the cells might play a role.
For example, it was reported that cytokeratin levels may be
low in breast cancer
A cell lines expressing high amounts of
vimentin such as MDA-MB-231 (Sommers et al., 1989).
A

Hence, the M30 assay may not be an ideal test to detect
apoptosis in such cell lines. We further evaluated the mode
of cell death induced by UFE by fluorescence imaging on
the basis of nuclear morphology. According to the results,
we observed that UFE resulted in cell/nuclear shrinkage in
some cells, which is also a hallmark of apoptosis (Figures
3A and 3B). As a result, although we could not detect

A

B

B
B

Figure 3. Fluorescence imaging for determination of cell death mode in MCF-7 (A) and MDA-MB-231 (B) cells. Cells were treated
with 100 µg/mL UFE for 72 h. The left panel shows Hoechst 33342 staining, while the middle and right panels show calcein-AM and
propidium iodide (PI) staining, respectively. Arrows show the pyknotic/fragmented nucleus of apoptotic cells.

944

ÇELİKLER KASIMOĞULLARI et al. / Turk J Biol

Janicke, 1999) and caspase 3 is a central effector caspase
in many types of cells and mediates the cleavage of itself,
other downstream caspases, and other caspase substrates
such as cytokeratin 18, and PARP (Gown and Willingham,
2002). In MDA-MB-231 cells, caspase-3 activation (~1.5
fold) and PARP cleavage (~2-fold) were induced by 100 µg/
mL UFE (Figures 4A and 4C). Therefore, we suggest that
UFE may induce apoptotic cell death through the caspasedependent pathway in MCF-7 and MDA-MB-231 cell
lines. In fact, in the literature, to the best of our knowledge,
there is no information about the mechanism of action of
U. filipendula that leads to cell death.
3.4. Genotoxicity assays
The results of genotoxicity tests are summarized in Tables
1 and 2. Table 1 shows the effect of UFE (125, 250, and
500 µg/mL), positive (EMS, 1250 µg/mL), solvent (DMSO
50%), and negative controls on the mitotic and nuclear
division index, the number of CAs, the frequency of
abnormal metaphases, and micronuclei frequency in
human lymphocyte cell cultures.

apoptosis in the MDA-MB-231 cell line by measuring M30
levels, it was clearly evident from the Hoechst 33342/PI/
calcein-AM triple staining experiment in which pyknotic
and fragmented nuclei, a well-known feature of apoptosis,
were present.
3.3. Effect of UFE on caspase-3 activation and cleaved
PARP
To detect cleaved PARP, which is a marker of caspasemediated apoptosis, we treated the MCF-7 and MDAMB-231 cells for 72 h with 100 µg/mL of UFE. The
cleaved-PARP levels were increased approximately 11fold by UFE in MCF-7 cells with the ELISA assay (Figure
4A). ELISA assay results confirm the findings of Western
blotting for PARP cleavage in MCF-7 cells (Figure 4B). On
the other hand, in MDA-MB-231 cells, the cleaved-PARP
levels were increased ~2-fold compared to untreated cells
as a consequence of UFE treatment. The resulting PARP
cleavage in both cell lines indicates apoptosis. In addition,
caspase activation (cleavage of procaspase to active
caspase) is regarded as a hallmark of apoptosis (Porter and
A

B

C

MCF- 7

MDA-MB-231

12
Cleaved PARP
(Fold Change)

kDa

UFE

8

— 116 PARP

6

1.5
1

— 89 Cleaved PARP

4
2
0

Caspase -3 Activity
(Fold Change)

Control

10

2

0.5

— 43 β - actin
MCF-7

0

MDA-MB-231

Control

UFE

Figure 4. Cleaved PARP levels in MCF-7 and MDA-MB-231 cell lines after 72 h of Usnea filipendula extract (UFE)
(100 µg/mL) treatment were examined by ELISA (A). Cleaved PARP levels in MCF-7 cell line examined by Western
blotting (B). Active caspase-3 levels in MDA-MB-231 cell line examined by ELISA (C). *Denotes significant change
from control (P < 0.05).
Table 1. Frequencies of chromosomal aberrations (CAs), micronuclei (MN), nuclear division index (NDI), and mitotic index (MI ‰)
in cultured human lymphocytes treated with Usnea filipendula Stirt. extract (UFE), and positive and negative controls (mean ± SD).
Number of chromosome aberrations
CG

ICG

CB

ICB

EXC

SE

PLV

TA(G+P)
± SDa

TA(G-P)
± SDa

MN ± SDa

NDI ± SDa

8.11 ± 2.54

0

0

0

0

0

0

0

0.00 ± 0.00

0.00 ± 0.00

12.00 ± 2.00

1.16 ± 0.04

8.50 ± 1.08

104

12

44

42

0

0

0

1.22 ± 0.31

0.63 ± 0.07

21.83 ± 5.10

1.38 ± 0.09

125 µg/mL UFE

7.30 ± 0.92

156

40

56

72

0

0

1.67 ± 0.63*

0.77 ± 0.24*

17.90 ± 3.48

1.36 ± 0.02

250 µg/mL UFE

6.70 ± 0.85

186

60

72

74

0

22

0

2.08 ± 1.08**

0.93 ± 0.51*

20.63 ± 5.12

1.21 ± 0.03**

500 µg/mL UFE

6.27 ± 0.15

108

42

34

72

0

14

0

1.40 ± 0.05

0.63 ± 0.22

24.63 ± 10.19

1.27 ± 0.04

EMS

3.34 ± 1.92

38

24

26

12

21

2

6

1.61 ± 0.37

0.66 ± 0.19

34.05 ± 2.12

1.09 ± 0.34

Treatments

‰ MI ± SDa

Negative control
Solvent control

10

CG, chromatid gap; ICG, iso-chromatid gap; CB, chromatid break; ICB, iso-chromatid break, EXC, exchange figure; SE, spiralization error; PLV, pulverization;
MI, mitotic index; TA(G+P), total chromosome aberration including gaps and pulverizations; TA(G-P), total chromosome aberration excluding gaps and
pulverizations; MN, micronuclei frequency (‰); NDI, nuclear division index; UFE, Usnea filipendula methanolic extract; SD, standard deviation; EMS, methyl
methane sulfonate as positive control (1250 µg/mL).
a, significance of UFE doses compared with DMSO solvent control; *, P < 0.05; **, P < 0.005
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Table 2. Results of comet analysis in cultured human lymphocytes treated with Usnea filipendula Stirt. extract (UFE), and positive and
negative controls (mean ± SD).
Treatments
(µg/mL)

Comet
engtha

Average
comet
densitya

Tail lengtha

% Tail DNAa

Olive tail
momenta

% Head
DNAa

Genetic damage
index (GDI)a

% Damaged
cella

Negative control

29.73 ± 3.02

0.14 ± 0.02

3.47 ± 1.29

2.43 ± 2.20

0.32 ± 0.30

97.57 ± 2.20

0.21 ± 0.03

0.01 ± 0.01

Solvent control

28.14 ± 3.07

0.1 ± 0.02

3.37 ± 1.00

2.76 ± 1.56

0.35 ± 0.20

97.24 ± 1.56

0.31 ± 0.05

125

30.32 ± 6.02

0.12 ± 0.03

5.27 ± 5.82

5.33 ± 10.36

0.90 ± 2.08

94.67 ± 10.36

0.39 ± 0.09

250

33.48 ± 10.52

0.12 ± 0.03

8.02 ± 10.91

7.91 ± 11.53

1.65 ± 4.14

92.09 ± 11.53

0.83 ± 0.08***

0.23 ± 0.01***

500

31.73 ± 6.32

0.12 ± 0.03

7.02 ± 6.41

9.83 ± 15.36

1.54 ± 2.74

90.17 ± 15.36

0.89 ± 0.03***

0.22 ± 0.02***

EMS

110.30 ± 17.22 94.31 ± 9.25

56.82 ± 10.54

5.92 ± 3.33

0.13 ± 0.03

3.69 ± 9.25

3.88 ± 0.04

0.97 ± 0.02

0.00 ± 0.00
*

0.11 ± 0.03***

UFE, Usnea filipendula methanolic extract; SD, standard deviation; EMS, methyl methane sulfonate as positive control (1250 µg/mL).
a, significance of UFE doses compared with DMSO solvent control; *, P < 0.05; ***, P < 0.001

As presented in Table 1, 125 and 250 µg/mL UFE
treatment significantly increased CAs in comparison with
the solvent control when gap and pulverized metaphase
were both included and excluded (P < 0.05 and P <
0.005, respectively). The 500 µg/mL dose did not show a
genotoxic effect.
Chromatid gaps and breaks, iso-chromatid gaps
and breaks, and other subchromatid aberrations were
the most common chromosomal abnormalities. An
insignificant decrease in the frequency of mitotic index
was detected for the treatment with UFE (P > 0.05). There
was a significant increase in the frequency of the CAs
when gap and pulverized metaphase were both included
(TGAP, P < 0.05–0.005) and excluded (TGEP, P < 0.05–
0.005) compared with the control at 125 and 250 µg/mL
concentrations.
The positive control group EMS at 1250 µg/mL
concentration significantly increased the number of
abnormal metaphases and the total structural CAs
compared to the negative control (P < 0.05).
The results of the MN assay are also shown in Table
1. The effects of all doses of UFE were not statistically

significant on MN frequency (P > 0.05). When we
compared the nuclear division index (NDI), we also found
significant differences in the 250 µg/mL dose of UFE (P <
0.005, Table 1). Table 2 shows the effect of UFE, positive,
solvent, and negative controls on the comet frequency
and genetic damage indexes in human lymphocyte cell
cultures. UFE extract also induced a significant increase
in GDI and damage frequency compared with the negative
control at all tested concentrations (P < 0.05 and P < 0.001,
Table 2).
In conclusion, the findings suggest that methanol
extract of U. filipendula has anticancer activity against
breast cancer cell lines by inducing apoptosis. In addition,
U. filipendula had genotoxic activity on lymphocytes that
was evident only at higher concentrations.
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